OUR STORIES AMPLIFIED
Explore recent news and articles amplifying our movement.


“With this law, the American people won and the special interests lost,” Biden told an audience of Democratic members of Congress and administration officials.


A proposal in the Democrats’ reconcilation bill could force some providers to close or limit medications.


A proposal could prohibit a PBM from "spread pricing" and "pharmacy clawbacks" unless it passes all rebates and concessions to health plans and discloses important pricing information.


A new Senate proposal could hinder drugmakers from producing generic version of traditional drugs.


Patient and patient advocate Beth Waldron used her social media platform to criticize CVS Caremark’s removal of Eliquis (apixaban) from its national formulary. CVS took notice.